Serum IgE levels in neurofibromatosis 1

• Published in: International Journal of Immunogenetics 2006-04, Vol.33 (2), p.111-115
• Main Authors: Geller, M., Ribeiro, M. G., de Q.C. Araújo, A. P., de Oliveira, L. J. B., Nunes, F. P.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Child; Female; Humans; Immunoglobulin E - blood; Male; Neurofibromatosis 1 - blood; Neurofibromatosis 1 - diagnosis; Neurofibromatosis 1 - immunology; Sex Factors
• ISSN: 1744-3121; 1744-313X; 1365-2370
• DOI: 10.1111/j.1744-313X.2006.00579.x

Summary A descriptive case study was performed on 75 patients with NF1 (neurofibromatosis type 1) from the CNNF (Brazil) database. Serum IgE levels were determined using the IgE radioimmunosorbent test, with the reference values of 75–502 IU mL−1. The patients were divided into groups, with 25 patients presenting plexiform neurofibromas, 25 presenting neurofibromas and 25 presenting no neurofibromas. The purposes of this study were to determine the serum IgE levels of patients with NF1 presenting plexiform neurofibromas, neurofibromas and no neurofibromas, as well as to determine possible correlations between serum IgE levels and the size of the plexiform neurofibromas and neurofibromas presented by these patients. Elevated serum IgE levels were observed in all the patient groups. We did not observe a correlation between IgE levels and age in these patients; however, we did observe correlations between IgE levels and neurofibroma and plexiform neurofibroma size. We suggest further studies to confirm these results and to investigate in greater depth the possible role of IgE in the development and growth of neurofibromas and plexiform neurofibromas in NF1.